Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q3 2024 · 10-Q
Revenue$20.52K$20.52Kno prior Q3 2023 on file Net Income-$2.88M-$2.88MN/M vs Q3 2023 EPS Diluted-$4.13-$4.13N/M vs Q3 2023 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,402,631N/M Margins · derivedGross margin76.4%
Operating margin-6919.4%
Net margin-14028.4%
ended Sep 30, 2024 · filed Nov 14, 2024 · 45 d after period end